Clinical Trials Directory

Trials / Completed

CompletedNCT01824667

Effect of B-GOS on GI Discomfort in Healthy Adults

Double-blind, Placebo Controlled, Randomised, Multicentered, of Parallel Design Study to Determine the Effect of B-GOS on GI Discomfort in Healthy Adults

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
400 (actual)
Sponsor
Clasado Limited · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to evaluate the effects of a new food supplement which is currently available in the market, called Bimuno® (B-GOS), on gastrointestinal discomfort (e.g. bloating, abdominal pain/cramp and flatulence) in adults who often experience these symptoms but are otherwise healthy. About 400 volunteers will take part in this study, which will last 6 weeks (to include 4 weeks treatment and 2 weeks follow up period). Episodes of abdominal pain or discomfort (e.g. bloating, abdominal pain/cramp and flatulence), in the absence of diseases, are commonly associated with food or drug intake or with alterations of bowel habit and vary between individuals in frequency and severity. Some dietary ingredients are known to reduce these symptoms. We have used B-GOS previously in trials with healthy younger and older adults and we have observed a trend towards reducing abdominal bloating. However, the investigators have not tested B-GOS in healthy adults who often experience these symptoms and this is what we will investigate now.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTB-GOS
DIETARY_SUPPLEMENTMaltodextrin

Timeline

Start date
2013-02-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2013-04-05
Last updated
2013-11-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01824667. Inclusion in this directory is not an endorsement.